Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
3.370
-0.030 (-0.88%)
Jul 16, 2026, 4:00 PM EDT - Market closed
Quantum BioPharma Market Cap
Quantum BioPharma has a market cap or net worth of $21.65 million as of July 17, 2026. Its market cap has decreased by -58.68% in one year.
Market Cap
21.65M
Enterprise Value
15.97M
1-Year Change
-58.68%
Ranking
Category
Stock Price
$3.37
ChartMarket Cap Chart
Since January 9, 2020, Quantum BioPharma's market cap has decreased from $53.50M to $21.65M, a decrease of -59.53%. That is a compound annual growth rate of -12.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 13.10M | -53.05% |
| Dec 31, 2025 | 27.90M | 304.35% |
| Dec 31, 2024 | 6.90M | -80.94% |
| Dec 29, 2023 | 36.20M | 20.67% |
| Dec 30, 2022 | 30.00M | -27.18% |
| Dec 31, 2021 | 41.20M | 108.08% |
| Dec 31, 2020 | 19.80M | -62.99% |
| Jan 9, 2020 | 53.50M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evaxion | 25.48M |
| Marker Therapeutics | 24.43M |
| Akari Therapeutics, | 23.88M |
| NextCure | 23.62M |
| VYNE Therapeutics | 23.48M |
| Celularity | 22.29M |
| Skye Bioscience | 21.82M |
| Tevogen Bio Holdings | 21.65M |